12.5 C
New York
Thursday, May 26, 2022

SeaSpine Holdings Corporation (SPNE) stock is down in the aftermarket – Here’s why?

SeaSpine Holdings Corporation (SPNE) stock has seen a decrease of 14.32% in the aftermarket. However, the last trading session closed at $16.34 with an incline of 0.68%.

Cantor Virtual Global Healthcare Conference

It is announced on 22 September 2021 that SPNE will speak at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021, at 8:00 a.m. ET. Moreover, the event will be streamed live and archived on the Company’s Investor Relations Website at investor.seaspine.com.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


SPNE will Host Analyst & Investor Event

On 16th September 2021, SPNE reported that on Thursday, September 30th, from 7:30 a.m. to 8:45 a.m. Eastern Time, it would conduct an Analyst & Investor Event in Boston, Massachusetts.

Moreover, members of the SeaSpine executive team will speak about the company’s distinctive technology and growth plan during the meeting. On the SeaSpine website, www.investor.seaspine.com, a live webcast with a PowerPoint presentation will be accessible. Following the meeting, an archived replay will be accessible on the Company’s website.

OrthoPediatrics Announces Entry into a Distribution Agreement with SPNE

On 9th September 2021, SPNE announced that they’ve agreed to exclusively market the 7D Surgical FLASHTM Navigation technology. With market-leading, radiation-free navigation technology, and a 5-year exclusive partnership, OrthoPediatrics can better serve the complete patient continuum of care for pediatric orthopedic surgeons.

In addition, the 7D FLASH Navigation System is the only image guidance system with a new and exclusive camera-based technology and machine vision algorithms. Furthermore, the method relies solely on visible light. This minimizes radiation exposure by obviating the need for intra-operative CT and fluoroscopy for registration. This allows surgeons to manage the system within the sterile field with a registration procedure that takes only seconds.

SPNE Announces Initial Launch of Mariner Adult Deformity System

On 7th September 2021, SPNE announced the Mariner Adult Deformity Pedicle Screw System’s limited commercial availability and completion of pilot surgeries.

Also, to address the specific clinical requirements of complicated adult deformity spine patients, SeaSpine continues to expand on the strength and adaptability of its basic Mariner Pedicle Screw System. To offer quick and forceful surgical intervention, this limited commercial launch incorporates sophisticated reduction and correction instruments, specific implant technologies, and sturdy osteotomy tools.

Commercial Launch of the WaveForm A (ALIF) 3D-Printed Interbody System

On 12th August 2021, SPNE stated that WaveForm A (ALIF) Interbody System, a 3D-printed interbody system, is now available for a limited time. Firstly, the ALIF technique is intended for WaveForm A. It easily interacts with the Meridian anterior interbody portfolio. WaveForm A is a completely porous interbody with a graft aperture. It can accommodate a significant amount of SeaSpine’s finest allograft demineralized bone matrix OsteoStrand and OsteoStrand Plus.

Secondly, the WaveForm A interbody takes 3D-printed architectural innovation to the next level. WaveForm A is a highly porous and durable interbody solution made possible by revolutionary WaveForm technology. Thirdly, this design aims to strike a compromise between subsidence resistance, implant stiffness, and orthobiologics packability, all while preserving radiographic visibility during intraoperative and postoperative imaging.

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here